Oral tetracyclines and erythromycin are the most effective treatments for POD. Other excellent treatments include topical clindamycin, erythromycin, and metronidazole.

One percent metronidazole cream is effective when applied twice daily (Veien et al., 1991). In one case series, 79% of patients responded to 2% erythromycin ointment (Weber, 2003).

In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Ruxolitinib 0.75% cream and ruxolitinib 1.5% cream are effective and well-tolerated in children aged 2 to 11 years with atopic dermatitis.

This study reveals that dupilumab is associated with a modestly increased risk of developing psoriasis, highlighting the importance of monitoring skin reactions during therapy.

Young patients with atopic dermatitis prioritize different treatment goals and have varying preferences from their caregivers.

The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.

A decade-long bibliometric analysis revealed rising global interest in atopic dermatitis–related itch, with an emerging focus ...

The use of dupilumab for the treatment of atopic dermatitis was associated with an increased risk of psoriasis compared with other systemic agents. The association between dupilumab and psoriasis ...

Galderma has shared positive two-year data for its monoclonal antibody Nemluvio (nemolizumab) in moderate-to-severe atopic dermatitis. The ARCADIA long-term extension (LTE) study has been evaluating ...